BLAINJECTIONINJECTABLE
Approved
Feb 2020
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
VYEPTI (eptinezumab-jjmr) by Lundbeck is calcitonin gene-related peptide antagonists [moa]. First approved in 2020.
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VYEPTI (eptinezumab-jjmr) is a monoclonal antibody antagonist of calcitonin gene-related peptide (CGRP) approved by the FDA on February 21, 2020. It is administered via intravenous injection for the preventive treatment of migraine. As a CGRP antagonist, it works by blocking the CGRP pathway, which plays a key role in migraine pathophysiology. VYEPTI represents an important addition to the migraine prevention armamentarium alongside oral and subcutaneous CGRP inhibitors.
$0.0BPart D
Mechanism of Action
Calcitonin Gene-related Peptide Antagonists
Pharmacologic Class:
Calcitonin Gene-related Peptide Antagonist
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
VYEPTI requires specialized commercial infrastructure including field teams trained in IV therapy administration protocols, neurologist relationships, and infusion center partnerships. Key roles include neurology-focused brand managers, medical science liaisons, and reimbursement specialists navigating the IV migraine treatment segment. Currently zero open positions are linked to this product, suggesting a stable, mature commercial team without active hiring.
Company
Worked on VYEPTI at Lundbeck? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.